Limited Edition Golden Llama is here! Check out how you can get one.
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free!
Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service?
Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available!
Here come GMP Grade Cytokines!Free Sample is available!
FACS analysis of Alpha-synuclein (GFP) on HEK293/Human Alpha-synuclein (GFP) Stable Cell Line.
HEK293/Human Alpha-synuclein (GFP) Stable Cell Line was red line, negative control HEK293 cells was grey line (QC tested).
Immobilized Human Alpha-Synuclein (E46K), Tag Free (Cat. No. ALN-H5117) at 1 μg/mL (100 μL/well) can bind Synuclein alpha/beta Monoclonal Antibody with a linear range of 0.1-4 ng/mL (QC tested).
The purity of Human Alpha-Synuclein (E46K), Tag Free (Cat. No. ALN-H5117) is more than 95% and the molecular weight of this protein is around 13-20 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Buntanetap | ANVS-405; ANVS-401 | Phase 3 Clinical | Raptor Pharmaceutical | Down Syndrome; Chronic Traumatic Encephalopathy; Alzheimer Disease; Parkinson Disease; Cognitive Dysfunction; Frontotemporal Dementia | Details |
Lu AF-82422 (Lundbeck A/S) | Lu AF-82422; Lu AF82422; Lu-AF82422 | Phase 3 Clinical | H. Lundbeck A/S, Genmab A/S | Parkinson Disease; Multiple System Atrophy | Details |
MEDI-1341 | MEDI-1341; TAK- 341 | Phase 2 Clinical | Astrazeneca Plc, Takeda Pharmaceutical Co Ltd | Parkinson Disease; Multiple System Atrophy | Details |
Prasinezumab | PRX-002; RG-7935; NEOD-002; RO-7046015 | Phase 2 Clinical | Prothena | Parkinson Disease | Details |
Kenterin | ENT-01; kenterin; Enterin-01 | Phase 2 Clinical | Enterin Inc | Constipation; Parkinson Disease; Dementia | Details |
UB-312 | UB-312 | Phase 2 Clinical | United Neuroscience Ltd | Parkinsonian Disorders; Parkinson Disease; Multiple System Atrophy | Details |
PBT-434 | PBT-434; ATH-434 | Phase 2 Clinical | Prana Biotechnology Ltd | Multiple System Atrophy | Details |
MT101-5 | MT101-5 | Phase 2 Clinical | Mthera Pharma Co Ltd | Parkinson Disease | Details |
AMDX-2011P | AMDX2011P; AMDX-2011P | Phase 2 Clinical | Amydis Inc | Cerebral Amyloid Angiopathy; Glaucoma, Open-Angle; Parkinson Disease; Alzheimer Disease; Amyotrophic Lateral Sclerosis | Details |
ACI-7104 | ACI-7104.056; ACI-7104 | Phase 2 Clinical | Ac Immune Sa | Parkinson Disease | Details |
Minzasolmin | UCB-1332; NPT200-11; DLX-313; DLX313; UCB-0599 | Phase 2 Clinical | Neuropore Therapies Inc | Parkinson Disease | Details |
Exidavnemab | PD-0805; BAN-0805; BBV-0805; ABBV-0805; PR-1808164 | Phase 2 Clinical | Bioarctic Ab | Parkinson Disease | Details |
Emrusolmin | TEV-56286; TEV-286; TEV-286; Anle-138b | Phase 2 Clinical | Ludwig-Maximilians-University, Max Planck Institute for Biophysical Chemistry | Parkinson Disease; Multiple System Atrophy | Details |
ION-464 | BIIB-101; IONIS-BIIB6 Rx; ION-464 | Phase 1 Clinical | Ionis Pharmaceuticals Inc | Multiple System Atrophy | Details |
SAR-446159 | ABL-301; SAR-446159 | Phase 1 Clinical | Abl Bio Inc | Parkinson Disease | Details |
AB-16 | AB-16 | Phase 1 Clinical | Autotac Bio Inc | Parkinson Disease | Details |
ACI-12589 | ACI-12589; a-syn-PET tracer (AC Immune); [18F]MNI-1216; [18F]ACI-12589 | Phase 1 Clinical | Ac Immune Sa, Biogen Inc, Invicro Llc | Synucleinopathies; Parkinson Disease; Lewy Body Disease; Multiple System Atrophy | Details |
PK-081 | PK081; PK-081 | Phase 1 Clinical | PharmaKure Ltd | Parkinson Disease | Details |
SNP201 | SNP201; SNP-201 | Phase 1 Clinical | SciNeuro Pharmaceuticals | Parkinson Disease | Details |
[18F]UCB-2897 | Phase 1 Clinical | Invicro Llc | Parkinsonian Disorders; Parkinson Disease; Multiple System Atrophy | Details | |
ACI-3847 | ACI-3847; 18F-ACI-3847 | Phase 1 Clinical | Ac Immune Sa, Biogen Inc | Parkinson Disease; Neurodegenerative Diseases | Details |
UCB-7853 | UCB-7853 | Phase 1 Clinical | Ucb Biopharma Srl | Parkinson Disease | Details |
Syneuro (Indus Biotech) | Clinical | Indus Biotech Pvt Ltd | Parkinson Disease | Details |
This web search service is supported by Google Inc.